Skip to content
Home
Register your family
Donate
About
What is Angelman syndrome?
Symptoms
Causes
Diagnosis & Tests
Treatment & Care
Angelman Syndrome Foundation
Our History
Board of Directors
Committees & Groups
Play Video
What is Angelman syndrome?
Symptoms
Causes
Diagnosis & Tests
Treatment & Care
Angelman Syndrome Foundation
Our History
Board of Directors
Committees and Groups
Research
Angelman Syndrome Research
Types of Research
ASF Funded Research
Call For Proposals
Research Studies 101
Participate in a Study
Active Studies
For Industry
Published Articles
Clinical Trials 101
Treatments & Therapies
Phases & Therapeutic Pipeline
Find a Clinical Trial
Angelman Syndrome Research
Types of Research
ASF Funded Research
Call for Proposals
Research Studies 101
Participate In A Study
Active Studies
For Industry
Published Articles
Clinical Trials 101
Treatments & Therapies
Phases & Therapeutic Pipeline
Find a Clinical Trial
Make an Impact
Ways to Donate
Donate Online
Join the ASF Cure Club
Text to Give
Send Sunshine
Start a Fundraiser
Programs & Events
Tips & Tools
Meet Fundraisers
Volunteer Opportunities
Join a Group or Committee
Shop & Support
Ways to Donate
Donate Online
Join the ASF Cure Club
Text to Give
Send Sunshine
Start a Fundraiser
Programs & Events
Tips & Tools
Meet Fundraisers
Volunteer Opportunities
Join a Group Or Committee
Shop & Support
ASF Clinics
Find an ASF Clinic
Europe
North America
South America
The Middle East
For Families
Clinic Patient Survey
FAQs
For Clinicians
Jacob Pritzker Fellowship
Clinical Care Tool Kit
Published Articles
Join the Network
Find an ASF Clinic
Europe
North America
South America
The Middle East
For Families
Clinic Patient Survey
FAQs
For Clinicians
Jacob Pritzker Fellowship
Clinical Care Toolkit
Angelman Publications
Join the Network
Find Resources
Resource Library
Newly Diagnosed
Adults
Family Support
Search by Sub-Topic
Advocacy
Financial Planning & Support
Individualized Education Plan (IEP)
ASF Podcast
Resource Library
Newly Diagnosed
Adults
Family Support
Search by Sub-Topic
Advocacy
Financial Planning & Support
Individualized Education Plan
ASF Podcast
Events
Events Calendar
Angelman Strong
Conferences & Symposia
Chicago Marathon
Tell Us About Your Event
Event Calendar
Angelman Strong
Conferences and Symposia
Chicago Marathon
Tell Us About Your Event
News & Blog
Contact Us
Donate
Register Your Family
About
What is Angelman syndrome?
Symptoms
Causes
Diagnosis & Tests
Treatment & Care
Angelman Syndrome Foundation
Our History
Board of Directors
Committees and Groups
Research
Angelman Syndrome Research
Types of Research
ASF Funded Research
Call for Proposals
Research Studies 101
Participate In A Study
Active Studies
For Industry
Published Articles
Clinical Trials 101
Treatments & Therapies
Phases & Therapeutic Pipeline
Find a Clinical Trial
Make an Impact
Ways to Donate
Donate Online
Join the ASF Cure Club
Text to Give
Send Sunshine
Start a Fundraiser
Programs & Events
Tips & Tools
Meet Fundraisers
Volunteer Opportunities
Join a Group Or Committee
Shop & Support
ASF Clinics
Find an ASF Clinic
Europe
North America
South America
The Middle East
For Families
Clinic Patient Survey
FAQs
For Clinicians
Jacob Pritzker Fellowship
Clinical Care Toolkit
Angelman Publications
Join the Network
Find Resources
Resource Library
Newly Diagnosed
Adults
Family Support
Search by Sub-Topic
Advocacy
Financial Planning & Support
Individualized Education Plan
ASF Podcast
Events
Event Calendar
Angelman Strong
Conferences and Symposia
Chicago Marathon
Tell Us About Your Event
News & Blog
Contact Us
2025 Angelman Syndrome Foundation.
All rights reserved.
3015 E. New York Street, Suite A2 #285
Aurora, IL 60504
(800) 432-6435
info@angelman.org
News
&
Blog
Filters
Blog or News
All
News
Blog
Categories
Pharma/Clinical Trials
Treatment/Therapeutic
Advocacy
Awareness
Clinics
Families
Family Support
Research
Special Needs Safety
International Angelman Day
Illness Prevention
LADDER
ABOM
Latest
Ultragenyx Completes Enrollment of Phase 3 GTX-102
Learn more
Learn more
Rugonersen Phase 1 TANGELO Study Results Published in Nature Medicine
Learn more
Learn more
Ultragenyx Pharmaceutical Receives Breakthrough Therapy Designation from FDA for GTX-102
Learn more
Learn more
First Patient(s) Dosed in Ionis Phase 3 ION582 Study
Learn more
Learn more
MavriX Bio Announces New Potential Gene Therapy for Angelman Syndrome
Learn more
Learn more
Oak Hill Bio Obtain Global Rights for Rugonersen
Learn more
Learn more
Federal Scientific Agencies
Learn more
Learn more
Report on Mortalities in Angelman Syndrome
Learn more
Learn more
Angelman Syndrome Advocacy in the Current Federal Policy Environment
Learn more
Learn more
Community Advisory Board
Learn more
Learn more
First Patient(s) Dosed in Ultragenyx Phase 3 Aspire Study
Learn more
Learn more
Self-Care for the Caregiver
Learn more
Learn more
